Dissecting the human plasma proteome and inflammatory response biomarkers

Proteomics

Volumn 9, Issue 2, 2009, Pages 470-484

  Saha, Sudipto ^a,b   Harrison, Scott H ^a,b   Chen, Jake Yue ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Drug targets; Inflammatory response; Mass spectrometry; Plasma proteome

Indexed keywords

BIOLOGICAL MARKER; HU PROTEIN; PLASMA PROTEIN; PROTEOME;

ARTICLE; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN TISSUE; INFLAMMATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION;

BIOLOGICAL MARKERS; BLOOD PROTEINS; BRAIN CHEMISTRY; CYTOPLASMIC STRUCTURES; DATABASES, GENETIC; DIAGNOSIS; HUMANS; INFLAMMATION; KIDNEY; LIVER; LUNG; MYOCARDIUM; NEOPLASMS; PHARMACEUTICAL PREPARATIONS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 60349099059     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800507     Document Type: Article

References (42)

1. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
2. Aggarwal, B. B., Nuclear factor-kappaB: the enemy within. Cancer cell 2004, 6, 203-208.
3. Alper, C., Taggart, H. A., Plasma protein patterns in disease. Am. Pract. Dig. Treat. 1954, 5, 349-353.
4. Parfentjev, I. A., Johnson, M. L., The plasma protein pattern and its significance in geriatrics and cancer diagnosis. Geriatrics 1955, 10, 232-238.
5. Trusheim, M. R., Berndt, E. R., Douglas, F. L., Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat. Rev. 2007, 6, 287-293.
6. Williams, S. A., Slavin, D. E., Wagner, J. A., Webster, C. J., A cost-effectiveness approach to the qualification and acceptance of biomarkers. Nat. Rev. 2006, 5, 897-902.
7. Veenstra, T. D., Conrads, T. P., Hood, B. L., Avellino, A. M. et al., Biomarkers: mining the biofluid proteome. Mol. Cell. Proteomics 2005, 4, 409-418.
8. Petricoin, E. F., Belluco, C., Araujo, R. P., Liotta, L. A., The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat. Rev. Cancer 2006, 6, 961-967.
9. Liotta, L. A., Petricoin, E. F., Putting the "bio" back into biomarkers: orienting proteomic discovery toward biology and away from the measurement platform. Clin. Chem. 2008, 54, 3-5.
10. Ping, P., Vondriska, T. M., Creighton, C. J., Gandhi, T. K. et al., Afunctional annotation of subproteomes in human plasma. Proteomics 2005, 5, 3506-3519.
11. Berhane, B. T., Zong, C., Liem, D. A., Huang, A. et al., Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 2005, 5, 3520-3530.
12. Muthusamy, B., Hanumanthu, G., Suresh, S., Rekha, B. et al., Plasma proteome database as a resource for proteomics research. Proteomics 2005, 5, 3531-3536.
13. Liu, X., Valentine, S. J., Plasencia, M. D., Trimpin, S. et al., Mapping the human plasma proteome by SCX-LC-IMS-MS. J. Am. Soc. Mass Spectrom. 2007, 18, 1249-1264.
14. Saha, S., Harrison, S. H., Shen, C., Tang, H. et al., HIP2: An online database of human plasma proteins from healthy individuals. BMC Med. Genomics 2008, 1,12.
15. Shadforth, I., Bessant, C., Genome annotating proteomics pipelines: available tools. Expert Rev. Proteomics 2006, 3, 621-629.
16. Balkwill, F., Charles, K. A., Mantovani, A., Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer cell 2005, 7, 211-217.
17. Theodoropoulos, G., Papaconstantinou, I., Felekouras, E., Nikiteas, N. et al., Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J. Gastroenterol. 2006, 12, 5037-5043.
18. Oremek, G. M., Sauer-Eppel, H., Bruzdziak, T. H., Value of tumour and inflammatory markers in lung cancer. Anticancer Res. 2007, 27, 1911-1915.
19. Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., Sethi, G., Inflammation and cancer: how hot is the link? Biochem. Pharmacol. 2006, 72, 1605-1621.
20. States, D. J., Omenn, G. S., Blackwell, T. W., Fermin, D. et al., Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 2006, 24, 333-338.
21. Boyle, E. I., Weng, S., Gollub, J., Jin, H. et al., GO::TermFinder-open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics (Oxford, England) 2004, 20, 3710-3715.
22. Polanski, M., Anderson, L. N., Biomarker Insights 2006, pp. 1-48.
23. Wishart, D. S., Knox, C., Guo, A. C., Shrivastava, S. et al., DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006, 34, D668-D672.
24. Chen, Y., Zhang, Y., Yin, Y., Gao, G. et al., SPD-a web-based secreted protein database. Nucleic Acids Res. 2005, 33, D169-D173.
25. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D. et al., Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-29.
26. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S. et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498-2504.
27. Alfarano, C., Andrade, C. E., Anthony, K., Bahroos, N. et al., The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res. 2005, 33, D418-D424.
28. Hernandez-Toro, J., Prieto, C., De las Rivas, J., APID2NET: unified interactome graphic analyzer. Bioinformatics (Oxford, England) 2007, 23, 2495-2497.
29. Gasteiger, E., Gattiker, A., Hoogland, C., Ivanyi, I. et al., ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003, 31, 3784-3788.
30. Vastrik, I., D'Eustachio, P., Schmidt, E., Joshi-Tope, G. et al., Reactome: a knowledge base of biologic pathways and processes. Genome Biol. 2007, 8, R39.
31. Shargel, L., Applied Biopharmaceutics & Pharmacokinetics, McGraw-Hill, New York 2005.
32. Luster, A. D., Alon, R., von Andrian, U. H., Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 2005, 6, 1182-1190.
33. Spano, J. P., Milano, G., Rixe, C., Fagard, R., JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications. Eur. J. Cancer 2006, 42, 2668-2670.
34. Monks, N. R., Biswas, D. K., Pardee, A. B., Blocking antiapoptosis as a strategy for cancer chemotherapy: NF-kappaB as a target. J. Cell. Biochem. 2004, 92, 646-650.
35. Luo, J. L., Kamata, H., Karin, M., IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J. Clin. Invest. 2005, 115, 2625-2632.
36. Fryer, C. J., Archer, T. K., Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 1998, 393, 88-91.
37. Malchoff, D. M., Brufsky, A., Reardon, G., McDermott, P. et al., A mutation of the glucocorticoid receptor in primary cortisol resistance. J. Clin. Invest. 1993, 91, 1918-1925.
38. Poller, W., Faber, J. P., Scholz, S., Weidinger, S. et al., Missense mutation of alpha 1-antichymotrypsin gene associated with chronic lung disease. Lancet 1992, 339, 1538.
39. Tang, N., Tornatore, P., Weinberger, S. R., Current developments in SELDI affinity technology. Mass Spectrom. Rev. 2004, 23, 34-44.
40. Hu, L., Ye, M., Jiang, X., Feng, S., Zou, H., Advances in hyphenated analytical techniques for shotgun proteome and peptidome analysis-a review. Analytica Chim. Acta 2007, 598, 193-204.
41. Anderson, L., Hunter, C. L., Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5, 573-588.
42. Abbott, K. L., Aoki, K., Lim, J. M., Porterfield, M. et al., Targeted glycoproteomic identification of biomarkers for human breast carcinoma. J. Proteome Res. 2008, 7, 1470-1480.